Diversified Growth Company - Medtech DPM CHF H
LU2304351898
Diversified Growth Company - Medtech DPM CHF H/ LU2304351898 /
NAV02.09.2024 |
Diff.-0,2000 |
Ertragstyp |
Ausrichtung |
Fondsgesellschaft |
78,6500CHF |
-0,25% |
thesaurierend |
Aktien
weltweit
|
NS Partners ▶ |
Investmentstrategie
The objective is to achieve a better performance in a global equity market than the MSCI World Health Care Equipment and Supplies (USD) index by investing mainly in shares, certificates of shares and equity-like transferable securities that fall into the investment universe of the medical technology industry globally.
The Sub-Fund will have a diversified portfolio exposed to global equity markets (Europe, North America, Asia and emerging markets). The Sub-Fund promotes social and environmental characteristics by investing at least 85% of its net assets in shares, certificates of shares and equity-like transferable securities with exposure to global equity markets that exhibit strong ESG credentials, with a specific focus on CO2 emissions.
Investmentziel
The objective is to achieve a better performance in a global equity market than the MSCI World Health Care Equipment and Supplies (USD) index by investing mainly in shares, certificates of shares and equity-like transferable securities that fall into the investment universe of the medical technology industry globally.
Stammdaten
Ertragstyp: |
thesaurierend |
Fondskategorie: |
Aktien |
Region: |
weltweit |
Branche: |
Branche Gesundheit/Pharma |
Benchmark: |
MSCI World Health Care Equipment and Supplies (USD) index |
Geschäftsjahresbeginn: |
01.01 |
Letzte Ausschüttung: |
- |
Depotbank: |
UBS Europe SE, Luxembourg Branch |
Ursprungsland: |
Luxemburg |
Vertriebszulassung: |
Schweiz, Niederlande, Frankreich, Belgien, Italien, Spanien, Luxemburg |
Fondsmanager: |
NS Partners SA |
Fondsvolumen: |
25,98 Mio.
USD
|
Auflagedatum: |
11.02.2022 |
Investmentfokus: |
- |
Konditionen
Ausgabeaufschlag: |
3,00% |
Max. Verwaltungsgebühr: |
1,50% |
Mindestveranlagung: |
- CHF |
Weitere Gebühren: |
- |
Tilgungsgebühr: |
0,00% |
Laufende Kosten (08.02.2019): |
1,17% |
Wesentliche Anlegerinformation: |
Download (Druckversion) |
Fondsgesellschaft
KAG: |
NS Partners |
Adresse: |
11, Boulevard de la Foire, 1528, Luxembourg |
Land: |
Luxemburg |
Internet: |
www.nspgroup.com/
|
Veranlagungen
Aktien |
|
98,40% |
Barmittel und sonstiges Vermögen |
|
1,60% |
Länder
Nordamerika |
|
71,50% |
Schweiz |
|
17,20% |
Europa |
|
9,60% |
Sonstige |
|
1,70% |
Branchen
Gesundheitswesen |
|
98,40% |
Barmittel und sonst. VM |
|
1,60% |